Geneva - 26 November 2008

The R&D pharmaceutical industry, represented by EFPIA, JPMA, PhRMA and IFPMA, has committed itself to making available information on all clinical trials of importance to patients since January 2005.

The Council of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) approved an updated Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases.

This extends the range of trials that member companies should provide information about to include at a minimum all confirmatory and exploratory efficacy clinical trials.

Full text: IFPMA Clinical Trials Portal – Media